Analyst Ratings for Immunome Inc. (IMNM)
IMNM Rating Summary
IMNM Price Target Summary
- Highest: $40.00 (Evercore ISI)
- Lowest: $26.00 (Goldman Sachs)
- Average: $34.60
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$34.60 (+38.6%)
* Over Last 12-Mos
Rating Score: 9.4 / 10
Percentile Rank: 90%
Avg. $ Target:
$34.60 (+38.6%)
* Over Last 12-Mos
Rating Score: 9.4 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/28/2026 | Barclays | Lukas Shumway | New Coverage | Overweight (N/A) |
36.00 (N/A) |
21.91 (24.97) |
13.97% | Details |
| 2/12/2026 | H.C. Wainwright » Updated 7/9/2026 |
Andres Y. Maldonado | New Coverage | Buy (N/A) |
40.00 (N/A) |
23.41 (24.97) |
6.66% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
